Picture of Marechale Capital logo

MAC — Marechale Capital News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapMomentum Trap

Marechale Capital - Director Dealing



 



RNS Number : 0470B
Marechale Capital PLC
29 October 2026
 

29 October 2026

 

Marechale Capital plc

 

("Marechale" or the "Company")

 

Director Dealing

 

Marechale Capital plc, (AIM: MAC), the AIM-quoted digital merchant bank, announces that on 27 October 2026 it was informed that Mr. Mark Warde-Norbury, Executive Chairman of the Company, had, on the same day, sold a part of his shareholding, representing 1,020,000 ordinary shares of £0.008 each in the Company ("Ordinary Shares") at a price of 4.75 pence per Ordinary Share from his personal shareholding account, and subsequently purchased the same amount of Ordinary Shares at the same price, through his Self-Invested Personal Pension ("SIPP"), pursuant to a Bed and SIPP arrangement.

 

Following these transactions, the aggregate number of Ordinary Shares in which Mr. Warde-Norbury and persons closely associated with him are interested remains unchanged, as does their aggregate beneficial ownership.

 

Further details of the transactions are set out in the notification below, made in accordance with Article 19 of the UK Market Abuse Regulation.

 

The Directors of the Company take responsibility for this announcement.

 

Enquiries

 

Marechale Capital

Patrick Booth-Clibborn / Mark Warde-Norbury

 

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP (Nominated Adviser)

Jo Turner / Sandy Jamieson

 

Tel: +44 (0)20 7213 0880

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Joe Quinlan

marechale@vigoconsulting.com

Tel: +44 (0)20 7390 0230

 

 

About Marechale Capital plc

 

Marechale Capital plc is one of the UK's first publicly quoted, fully integrated digital merchant banks.

 

The Group bridges traditional and digital asset markets, sitting at the centre of a rapidly growing market for tokenised assets. The Group operates across four businesses - Marechale Capital, Stanford Capital Partners, Blubird Global Inc. and NJC Capital Management Limited - providing services across corporate finance, capital markets, tokenisation and asset management. This comprehensive offering is underpinned by ownership of the Blubird technology platform.

 

Marechale Capital plc is quoted on the AIM Market of the London Stock Exchange under the ticker MAC.

 

For more information: https://marechalecapital.com/

 

Forward looking statement disclaimer

 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

 

The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.



 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Mark Warde-Norbury

2

Reason for notification


a.

Position/Status

Executive Chairman

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Marechale Capital plc

b.

LEI

2138003NUK6SXCDIAT89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

Ordinary Shares

 

 

ISIN: GB0005401087

 

b.

Nature of the transaction

1)    Sale of 1,020,000 Ordinary Shares from personal shareholding account pursuant to a Bed and SIPP arrangement

2)    Purchase of 1,020,000 Ordinary Shares through Mr Warde-Norbury's SIPP pursuant to a Bed and SIPP arrangement

 

c.

Price(s) and volume(s):


Price(s) per share (p)

Volume(s)


1)    Sale: 4.75 pence

2)    Purchase: 4.75 pence

 

 

1)    Sale: 1,020,000

2)    Purchase: 1,020,000

 

 


d.

Aggregated information

-      Volume

-      Price

 

-      Volume

-      Price

 

1)    1,020,000

1)    4.75 pence

 

2)    1,020,000

2)    4.75 pence

 

e.

Date of the transaction

 

27 October 2026

 

 

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEWFEUEMSEDS

Recent news on Marechale Capital

See all news